Truist Securities Reiterates Buy Rating on GRDN
Truist Securities maintains its Buy rating on GRDN with a price target of $47.
Key Points
- Truist Securities reiterated its Buy rating on GRDN, setting a price target of $47 as of June 17, 2026.
- GRDN shares are trading at $42.42, reflecting analyst confidence despite market fluctuations.
- Institutional activity includes Driehaus Capital increasing its stake, while Silvercrest Asset Management reduced its holdings.
Important disclosure: EarningsIQ is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Truist Securities has reiterated its Buy rating on GRDN, setting a price target of $47. This update was made by analyst David Macdonald on June 17, 2026. GRDN shares are currently trading around $42.42.
Other Institutional Activity in GRDN
Driehaus Capital Management LLC increased its holdings in GRDN by 82,646 shares, bringing its total to 589,121 shares valued at approximately $22.2 million. Conversely, Silvercrest Asset Management Group LLC cut its stake by 397,635 shares, leaving it with 374,946 shares worth about $14.1 million. Peregrine Capital Management LLC also reduced its position by 19,453 shares, now holding 201,603 shares valued at $7.6 million. Ranger Investment Management, L.P. made a minor reduction, selling 475 shares, resulting in a total of 167,190 shares valued at $6.3 million.
Analysts Set New Price Targets
On June 17, 2026, Truist Securities maintained its Buy rating on GRDN with a $47 price target. B of A Securities also maintained a Buy rating, setting the same target of $47. Previously, on May 7, 2026, Oppenheimer maintained a Buy rating with a $43 target. Earlier, B of A Securities initiated coverage with a Buy rating and a $42 target on April 27, 2026.
About GRDN
GRDN operates in the [sector/industry], providing [products/services] to its customers. The company is headquartered in [location] and is led by CEO [CEO Name]. With a team of [number of employees] employees, GRDN focuses on [business focus or strategy].
Bottom Line
Truist Securities' reaffirmation of its Buy rating and a $47 price target suggests continued confidence in GRDN's prospects. The stock is currently trading at $42.42, indicating room for potential growth according to analysts. Institutional investors have shown mixed activity, with some increasing their stakes while others have trimmed their positions.
Get Guardian Pharmacy Services, Inc. alerts
New 13F filings, insider trades, and analyst moves on $GRDN, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.

S